Receive site and email notifications about comments and news clips that you are collaborating on!
"Numis Securities Ltd reaffirmed their add rating on shares of Spire Healthcare Group PLC (LON:SPI) in a report released on Thursday. They currently have a GBX 360 ($4.73) price objective on the stock. Other equities analysts have also issued reports about the company. Jefferies Group reaffirmed a hold rating and issued a GBX 335 ($4.40) […]", www.com-unik.info
"Jefferies Group reiterated their hold rating on shares of Spire Healthcare Group PLC (LON:SPI) in a report released on Thursday morning. Jefferies Group currently has a GBX 335 ($4.40) target price on the stock. Other equities analysts have also issued reports about the stock. Numis Securities Ltd restated an add rating and set a GBX […]", baseballnewssource.com
"Morgan Stanley reaffirmed their equal weight rating on shares of Spire Healthcare Group PLC (LON:SPI) in a research report released on Thursday. They currently have a GBX 340 ($4.47) target price on the stock. Other equities research analysts have also recently issued research reports about the company. Numis Securities Ltd reaffirmed an add rating and […]", www.thecerbatgem.com
"Patients fed up with long NHS waiting lists are increasingly turning to the private sector and paying out of pocket for medical procedures, helping to boost UK-listed hospital provider Spire Healthcare, its chief executive has said.", www.telegraph.co.uk
"Spire Healthcare Group PLC (LON:SPI)‘s stock had its “overweight” rating restated by research analysts at Barclays PLC in a note issued to investors on Friday. They presently have a GBX 382 ($5.02) price objective on the stock. Barclays PLC’s target price would indicate a potential upside of 8.40% from the company’s previous close. Shares of […]", www.thecerbatgem.com
"NHS waiting lists stretching ever longer will boost growth at Spire Healthcare, the private hospitals chain said, as it outlined expansion plans. Executive chairman Garry Watts said that, regardless of Brexit, “NHS funding constraints will continue to put pressure on waiting-list targets and the provision of a fully unrestricted, unrationed service to the UK public”. Increased demand for healthcare, which is also being fuelled by Britain’s growing, ageing population, helped revenues to climb 4.4% to £469.5 million in the first half. Shares rose 1p to 344p.", www.standard.co.uk